HALOZYME THERAPEUTICS, INC. (HALO)

SEC filing

HALOZYME THERAPEUTICS, INC.

HALO · CIK 1159036

4 · Oct 8, 2026 · Director, PRESIDENT AND CEO Torley Helen sold 60K shares at $110.18/share ($6.6M); exercised options for 120K shares

Director, PRESIDENT AND CEO Torley Helen sold 60K shares at $110.18/share ($6.6M); exercised options for 120K shares

FORM 4

xslF345X06/wk-form4_1791503775.xmlSEC.gov

Graphics and non-inline formats (not embedded below).